Protalix Biotherapeutics(PLX) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Protalix BioTherapeutics to Present at the IAccess Alpha Virtual Best Ideas Spring Conference 2025
PR NewswireMar 24 06:50 ET
Is Protalix BioTherapeutics (PLX) The High Growth Low Debt Stock to Invest in Now?
Yahoo FinanceMar 22 17:42 ET
IAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
AccesswireMar 21 09:00 ET
Protalix Stock (PLX) Grabbing Attention With Record Revenue Surge
TipRanksMar 19 21:55 ET
Small Cap Wrap: Fineqia, Candel Therapeutics, Ocean Power Technologies, Protalix Biotherapeutics...
Proactive InvestorsMar 18 15:50 ET
Protalix Biotherapeutics Gains Momentum: Analysts See Long-term Upside | NYSE-A:PLX
Proactive InvestorsMar 18 14:46 ET

Comments

Jaguar8

Oct 25, 2024 19:43

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024
Protalix BioTherapeutics (NYSE American:PLX) announced it will present data from its phase I clinical trial of PRX-115, a recombinant PEGylated uricase product candidate for uncontrolled gout treatment, at the ACR Convergence 2024. The presentation, titled 'Prolonged Plasma Urate-Lowering After a Single Intravenous Administration of PRX-115,' will be del...

1

Jaguar8

Jun 13, 2024 19:35

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical firm, will host an in-person investor day on June 26, 2024, at the Lotte Palace New York Hotel. The event will begin at 8:30 a.m. EDT. Key opinion leaders, including Aleš Linhart of Charles University and Naomi Schlesinger of the Univers...

Jaguar8

May 29, 2024 20:40

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical company specializing in recombinant therapeutic proteins via its ProCellEx® plant cell-based system, announced its participation at the 2024 BIO International Convention in San Diego, California. The convention, hosted by the Biotechnology Innovation Organization (BIO), is the largest industry event, gathering glo...